Page last updated: 2024-08-17

quinoxalines and bbm-928 a

quinoxalines has been researched along with bbm-928 a in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Diez, MT; Gagliardi, MM; Garrity, GM; Gartner, SE; Genilloud, O; Heimbuch, BK; Hirsch, CF; Hsu, AH; Koch, GE; Liesch, JM; Lingham, RB; Martin, I; O'Brien, JA; Salituro, GM; Sanchez, M; Sigmund, JM; Tsou, NN; Zink, DL	1
Bailly, C; Crow, S; Minnock, A; Waring, MJ	1
Dawson, S; Malkinson, JP; Paumier, D; Searcey, M	1

Reviews

1 review(s) available for quinoxalines and bbm-928 a

Article	Year
Bisintercalator natural products with potential therapeutic applications: isolation, structure determination, synthetic and biological studies. Natural product reports, 2007, Volume: 24, Issue:1 Topics: Biological Products; Depsipeptides; DNA; Echinomycin; Intercalating Agents; Peptides; Peptides, Cyclic; Quinolines; Quinoxalines	2007

Other Studies

2 other study(ies) available for quinoxalines and bbm-928 a

Article	Year
Quinoxapeptins: novel chromodepsipeptide inhibitors of HIV-1 and HIV-2 reverse transcriptase. I. The producing organism and biological activity. The Journal of antibiotics, 1996, Volume: 49, Issue:3 Topics: Actinomycetales; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Hydroxyquinolines; In Vitro Techniques; Kinetics; Molecular Structure; Mutation; Nucleic Acid Synthesis Inhibitors; Peptides, Cyclic; Quinoxalines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase	1996
DNA recognition by quinoline antibiotics: use of base-modified DNA molecules to investigate determinants of sequence-specific binding of luzopeptin. Nucleosides, nucleotides & nucleic acids, 2000, Volume: 19, Issue:8 Topics: 2-Aminopurine; Antiprotozoal Agents; Base Pairing; Base Sequence; Binding Sites; Deoxyribonuclease I; DNA; DNA Footprinting; DNA Replication; DNA, Bacterial; Echinomycin; Electrophoresis, Polyacrylamide Gel; Hydrogen Bonding; Hydroxyquinolines; Inosine; Intercalating Agents; Molecular Sequence Data; Molecular Structure; Peptides, Cyclic; Polymerase Chain Reaction; Quinolines; Quinoxalines; Structure-Activity Relationship	2000

Article

Year

Quinoxapeptins: novel chromodepsipeptide inhibitors of HIV-1 and HIV-2 reverse transcriptase. I. The producing organism and biological activity.

The Journal of antibiotics, 1996, Volume: 49, Issue:3

Topics: Actinomycetales; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Hydroxyquinolines; In Vitro Techniques; Kinetics; Molecular Structure; Mutation; Nucleic Acid Synthesis Inhibitors; Peptides, Cyclic; Quinoxalines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase

1996

DNA recognition by quinoline antibiotics: use of base-modified DNA molecules to investigate determinants of sequence-specific binding of luzopeptin.

Nucleosides, nucleotides & nucleic acids, 2000, Volume: 19, Issue:8

Topics: 2-Aminopurine; Antiprotozoal Agents; Base Pairing; Base Sequence; Binding Sites; Deoxyribonuclease I; DNA; DNA Footprinting; DNA Replication; DNA, Bacterial; Echinomycin; Electrophoresis, Polyacrylamide Gel; Hydrogen Bonding; Hydroxyquinolines; Inosine; Intercalating Agents; Molecular Sequence Data; Molecular Structure; Peptides, Cyclic; Polymerase Chain Reaction; Quinolines; Quinoxalines; Structure-Activity Relationship

2000